Hearing Loss Trial, Recruiting NCT07575334 Sponsor: Eye & ENT Hospital of Fudan University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07575334
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years
  • People who have been diagnosed with sudden sensorineural hearing loss (a type of unexplained hearing loss that came on within 72 hours and met specific hearing test thresholds)
  • People whose hearing loss affects one ear only, and who had equal hearing in both ears before this episode started (either by their own account or confirmed by a previous hearing test)
  • People whose symptoms started no more than 14 days before enrolling in the trial
  • People who are alert, can understand questions clearly, and are able to complete assessments
  • People who agree to take part and sign a written consent form

Who may not be able to join:

  • People whose hearing loss has a clearly identified cause found during examination, such as a nerve tumour near the ear (acoustic neuroma), stroke, head injury, or certain nerve-related conditions
  • People who had any previous hearing problems or balance problems in the affected ear before this episode, including past sudden hearing loss, certain types of migraine, Meniere's disease, positional vertigo, or hearing loss present from birth or caused by inherited conditions, syphilis, or a bone condition in the ear
  • People who have conditions where steroid medicines taken throughout the body are generally not recommended — for example, poorly controlled or insulin-dependent diabetes, a history of stomach ulcers, active infection or tuberculosis, a history of hepatitis B or C, pancreas problems, severe bone thinning (osteoporosis), or bone tissue loss (osteonecrosis)
  • People who have already received 10 or more days of steroid treatment (either throughout the body or locally in the ear) before enrolling
  • People who have other conditions — such as severe skin disorders — that would prevent them from completing acupuncture treatment
  • People who have serious problems with major organ function
  • People who have had acupuncture treatment at any point in the past 12 months
  • People who are pregnant or breastfeeding
  • People the trial investigator considers unsuitable for other reasons, such as difficulty attending follow-up appointments or concerns about not being able to follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-18017321721

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Eye & ENT Hospital of Fudan University
Registry
ClinicalTrials.gov
Start date
13 April 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Hearing improvement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov